Integrated identification of key immune related genes and patterns of immune infiltration in calcified aortic valvular disease: A network based meta-analysis

LD Wu, F Xiao, JY Sun, F Li, YJ Chen, JY Chen… - Frontiers in …, 2022 - frontiersin.org
Background: As the most prevalent valvular heart disease, calcific aortic valve disease
(CAVD) has become a primary cause of aortic valve stenosis and insufficiency. We aim to …

Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs

M Sarfraz, A Khan, L Eltaib, SMB Asdaq… - … -Research and Practice, 2024 - Elsevier
Prostate cancer (PCa) continues to be a major health concern worldwide, with its resistance
to chemotherapy and radiation therapy presenting major hurdles in successful treatment …

Identification of an immune-related prognostic signature for glioblastoma by comprehensive bioinformatics and experimental analyses

S Ye, B Yang, T Zhang, W Wei, Z Li, J Chen, X Li - Cells, 2022 - mdpi.com
Background: Glioblastoma (GBM), which has a poor prognosis, accounts for 31% of all
cancers in the brain and central nervous system. There is a paucity of research on …

Predicting prostate cancer recurrence: Introducing PCRPS, an advanced online web server

X He, S Hu, C Wang, Y Yang, Z Li, M Zeng, G Song… - Heliyon, 2024 - cell.com
Abstract Background Prostate cancer (PCa) is one of the leading causes of cancer death in
men. About 30% of PCa will develop a biochemical recurrence (BCR) following initial …

Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data

M Pellegrini - Scientific Reports, 2023 - nature.com
Localized prostate cancer is a very heterogeneous disease, from both a clinical and a
biological/biochemical point of view, which makes the task of producing stratifications of …

Immune cell infiltration-based prognosis in prostate cancer: a review of current knowledge

K Apusiga - Bulletin of the National Research Centre, 2023 - Springer
Background Despite the widespread use of tumor immune cell infiltrates as prognostic
biomarkers in many cancers, their use in prostate cancer remains relatively unexplored …

[HTML][HTML] A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma

C Ye, S Qin, S Qiu, L Zhao, J Miao… - Translational …, 2022 - ncbi.nlm.nih.gov
Background The 5-year overall survival rate in metastatic prostate adenocarcinoma (PRAD)
is extremely low. Genomic studies of PRAD have improved our understanding of disease …

[HTML][HTML] A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma

J Liu, Z Tan, S Yang, X Song, W Li - Aging (Albany NY), 2022 - ncbi.nlm.nih.gov
Prostate adenocarcinoma (PRAD) represents the most common male carcinoma in
developed countries, its high relapse risk contributes to the second-leading cause of cancer …

E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5

Q Wang, Q Yu, Y Liu - Immunity, Inflammation and Disease, 2023 - Wiley Online Library
Background E2F transcription factors are well‐recognized oncogenic molecules, and their
correlation with immune cell infiltration has recently been reported. This work studies the …

Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi

Y Wang, S Ye, D Wu, Z Xu, W Wei, F Duan, M Luo - Cancers, 2023 - mdpi.com
Simple Summary In this study; four immune-related predictive biomarkers for LGG were
identified and proven to be IRGs. The development of more efficient immunotherapy …